PhageaiS.A.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-04-15
Share capital
247 500,00 PLN
Activity description

Phageai is an AI-driven company specializing in software development and bioinformatics for phage research. It offers the PhageAI platform, which automates the analysis of bacteriophage characteristics, significantly reducing the time required for phage description and improving accuracy in taxonomy and life cycle classification. The platform serves various areas of phage research and therapy.

Registered address
ul. Płocka 35/43, 93-134 Łódź, Poland
Website
phage.aiWebsite active
Email
Email address current
Electronic delivery address
AE:PL-24533-71055-ECFHS-25

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2026.

Results vs industry

Revenue
This companyUSD 1.20kMedianUSD 107.82kAverageUSD 1.88m
Net profit
This companyUSD -307.07kMedianUSD 2.13kAverageUSD 129.21k
Operating costs
This companyUSD 9.86kMedianUSD 100.58kAverageUSD 1.54m
Assets
This companyUSD 17.56kMedianUSD 73.78kAverageUSD 1.24m

Bank accounts

Registered as a VAT taxpayer on 2021-07-23. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

2 active proceedings recorded in KRZ. Active proceeding

Registration dateProceeding typeStatus
Jun 3, 2026
Bankruptcy proceedings for an entrepreneur
In progress
Feb 2, 2026
Petition to declare entrepreneur bankruptcy
Closed

Public aid

5 public aid cases recorded, with a total value of $313,039.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$200
Aid for research and development projects: industrial research
$275.9K
Aid for research and development projects: experimental development
$32,316

Tenders

No recorded participation in tenders.

Authorized Representatives

Bruno Michel Maineult — President of the Management Board

Manner of representation

President of the Management Board or Vice-President independently, and a member of the management board jointly with the President of the Management Board, Vice-President or commercial proxy

Ownership

Owner
Proteon Pharmaceuticals S.A.

Beneficial owners

Person
Bruno Maineult (57)

Competitors

Name
IP Protectorsp. z o.o.
Ferma Prosp. z o.o.
Wk-Innovatesp. z o.o.
THE Future Labsp. z o.o.
Automatyzacjesp. z o.o.
Firstscoresp. z o.o.
Data Envoyssp. z o.o.
Volaria AiS.A.
Crewisesp. z o.o.

Change history

DateEvent
2026-06-16Name change
2024-03-08Address change
2024-03-08Share capital change
2023-08-23Share capital change
2021-04-15Entered in the register

FAQ

Last updated: 2026-07-24